Understanding and preventing gastric cancer caused by Helicobacter pylori infection

Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification

NIH-funded research Stanford University · NIH-10932166

This study is looking at how a common stomach bacteria might lead to stomach cancer, and it's for people who have precancerous changes in their stomach, helping to find out who might be at greater risk so we can catch problems early and prevent cancer.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-10932166 on NIH RePORTER

What this research studies

This research investigates how the bacterium Helicobacter pylori contributes to the development of gastric cancer by examining the molecular and cellular characteristics of precancerous lesions. It aims to identify which patients are at higher risk for developing invasive cancer based on their unique biological markers and the nature of their gastric environment. The study employs advanced techniques such as single-cell sequencing to analyze gastric epithelial cells and create models that simulate precancerous conditions. By stratifying patients based on their risk factors, the research seeks to improve early detection and prevention strategies for gastric cancer.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals infected with Helicobacter pylori who have been diagnosed with gastric intestinal metaplasia or are at risk for developing gastric cancer.

Not a fit: Patients who do not have Helicobacter pylori infection or those without any precancerous lesions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective screening and prevention strategies for gastric cancer, potentially saving lives.

How similar studies have performed: Previous research has shown promising results in understanding the role of Helicobacter pylori in gastric cancer, indicating that this approach could build on established findings.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.